hives, rash, respiratory distress, and swelling of the face, lip, mouth, eye, tongue, throat, and feet. In some reported cases, reactions were life-threatening and required emergency treatment.
Cases of life-threateningpancreatitishave been reported in both children and adults receiving valproate. Some of the cases have been described ashemorrhagicwith a rapid progression from initial symptoms to death. Cases have been reported shortly after initial use as well as after several years of use...
Inform patients that, should they divide the scored 600 mg or 800 mg NEURONTIN tablet in order to administer a half-tablet, they should take the unused half-tablet as the next dose. Half-tablets not used within 28 days of dividing the scored tablet should be discarded. If the NEURONTIN do...